Amphetamines are synthetic stimulants and were first created in 1887. These are among the most powerful stimulant-based smart drugs in use and work primarily by targeting dopamine, serotonin and noradrenaline/norepinephrine. Given what you’ve already learned about the dopaminergic effects of modafinil and methylphenidate, you should already be wary of amphetamines’ targeting of dopamine. Hormones and neurotransmitters such as dopamine, serotonin, norepinephrine and histamine are known as monoamines, and amphetamines block their uptake by being taken up instead themselves by monoamine transporters. This leads to higher levels of monoamines in synapses, and consequently to the psychostimulant effects characteristic of drugs like Adderall.
SOURCES: Ray Sahelian, MD. Psychopharmacology, September 2000. Human Psychopharmacology, July 2001; January 2002. Psychopharmacology Bulletin, Summer 2002. The Cochrane Database of Systematic Reviews, 2002. Archives of Neurology, November 1998. Zhongguo Yao Li Xue Bao, July 1999. Pharmacological Research, September 1999. International Clinical Psychopharmacology, March 2003. FDA web site.
For example, a study published in the journal Psychopharmacology in 2000 found that ginkgo improved attention. A 2001 study in the journal Human Psychopharmacology suggested that it improves memory. Nevertheless, in a review of studies on ginkgo in healthy people, researchers found no good evidence that it improved mental abilities, according to a 2002 report in Psychopharmacology Bulletin.
He used to get his edge from Adderall, but after moving from New Jersey to San Francisco, he says, he couldn’t find a doctor who would write him a prescription. Driven to the Internet, he discovered a world of cognition-enhancing drugs known as nootropics — some prescription, some over-the-counter, others available on a worldwide gray market of private sellers — said to improve memory, attention, creativity and motivation.